Gauglitz G - Search Results

1

Monophasic, cohesive-polydensified-matrix crosslinking-technology-based hyaluronic acid filler for the treatment of facial lipoatrophy in HIV-infected patients.

Pavicic T, Ruzicka T, Korting HC, Gauglitz G. Pavicic T, et al. Among authors: gauglitz g. J Drugs Dermatol. 2010 Jun;9(6):690-5. J Drugs Dermatol. 2010. PMID: 20645533

2

Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment.

Pavicic T, Gauglitz GG, Lersch P, Schwach-Abdellaoui K, Malle B, Korting HC, Farwick M. Pavicic T, et al. Among authors: gauglitz gg. J Drugs Dermatol. 2011 Sep;10(9):990-1000. J Drugs Dermatol. 2011. PMID: 22052267 Clinical Trial.

3

Becker nevus of the leg with lipoatrophy.

Gauglitz G, Müller DS, Molin S, Ruzicka T, Herzinger T. Gauglitz G, et al. JAMA Dermatol. 2013 Sep;149(9):1115-6. doi: 10.1001/jamadermatol.2013.4736. JAMA Dermatol. 2013. PMID: 23842724 No abstract available.

4

Safety of Cohesive Polydensified Matrix Cross-Linked Hyaluronic Acid Volumizing Gel in Temporal Hollows and Cheeks: A Prospective, Open-Label, Postmarket Study.

Pavicic T, Sattler G, Prager W, Fischer T, Gauglitz G, Hofmann M, Dersch H, Riaz S, Kerscher M. Pavicic T, et al. Among authors: gauglitz g. Dermatol Surg. 2021 Oct 1;47(10):1359-1364. doi: 10.1097/DSS.0000000000003176. Dermatol Surg. 2021. PMID: 34417392 Clinical Trial.

5

[Modern soft tissue augmentation--away from treating the single fold to volume replacement in the whole face].

Pavicic T, Gauglitz GG. Pavicic T, et al. Among authors: gauglitz gg. MMW Fortschr Med. 2012 Sep 10;154(15):51-2, 54. doi: 10.1007/s15006-012-1082-3. MMW Fortschr Med. 2012. PMID: 22997941 German. No abstract available.

6

Understanding the safety and tolerability of facial filling therapeutics.

Kulichova D, Borovaya A, Ruzicka T, Thomas P, Gauglitz GG. Kulichova D, et al. Among authors: gauglitz gg. Expert Opin Drug Saf. 2014 Sep;13(9):1215-26. doi: 10.1517/14740338.2014.939168. Epub 2014 Jul 18. Expert Opin Drug Saf. 2014. PMID: 25036318 Review.

7

[Anti-wrinkle creams with hyaluronic acid: how effective are they?].

Poetschke J, Schwaiger H, Steckmeier S, Ruzicka T, Gauglitz GG. Poetschke J, et al. Among authors: gauglitz gg. MMW Fortschr Med. 2016 May 25;158 Suppl 4:1-6. doi: 10.1007/s15006-016-8302-1. Epub 2016 May 25. MMW Fortschr Med. 2016. PMID: 27221554 German.

8

Erythema a computatro.

Gauglitz GG, Ruzicka T, Herzinger T. Gauglitz GG, et al. Case Rep Dermatol. 2013 Mar 29;5(1):111-3. doi: 10.1159/000350566. Print 2013 Jan. Case Rep Dermatol. 2013. PMID: 23626550 Free PMC article.

9

Botulinum toxin A for the treatment of keloids.

Gauglitz GG, Bureik D, Dombrowski Y, Pavicic T, Ruzicka T, Schauber J. Gauglitz GG, et al. Skin Pharmacol Physiol. 2012;25(6):313-8. doi: 10.1159/000342125. Epub 2012 Aug 31. Skin Pharmacol Physiol. 2012. PMID: 22948093

10

Calcium Hydroxyapatite Filler With Integral Lidocaine CaHA (+) for Soft Tissue Augmentation: Results from an Open-Label Multicenter Clinical Study.

Pavicic T, Sattler G, Fischer T, Dirschka T, Kerscher M, Gauglitz G, Dersch H, Kravtsov M, Heide I, Prager W. Pavicic T, et al. Among authors: gauglitz g. J Drugs Dermatol. 2022 May 1;21(5):481-487. doi: 10.36849/JDD.6737. J Drugs Dermatol. 2022. PMID: 35533030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters